MedTrace Logo

Optimized Radiological Diagnosis of Hepatic Candidiasis During the Treatment of Acute Leukemias

NCT01207843 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2014-08-19

No results posted yet for this study

Summary

Hepatic candidiasis is a frequent complication in patients receiving intensive chemotherapy for acute leukemia. Hepatic lesions may be detected by computerized tomographic (CT) scans, but there is no standardized CT protocol for the diagnosis and follow-up of hepatic candidiasis.

The investigators compared the size of the fungal lesions in the chest and abdomen CT. The current analysis aimed to increase the value of CT for the diagnosis and the follow-up of hepatic candidiasis in daily routine.

Conditions

Interventions

BEHAVIORAL

Imaging

CT image validation and lesion measurement, as well as comparison of different CT phases

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Thomas Frauenfelder, MD · UniversitaetsSpital Zuerich

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-04-30
Completion
2013-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01207843 on ClinicalTrials.gov